#USA #Boca Raton #Clinical Research #Chubb #Verified Clinical Trials

Strategic Partnership to Elevate Clinical Studies

In a groundbreaking development for clinical research, Verified Clinical Trials (VCT), a premier provider of participant registry solutions, has announced a strategic alliance with Chubb, a global leader in insurance for clinical trials. This partnership aims to significantly enhance participant safety, improve data quality, and ultimately contribute to the overall success of clinical trials.

Objectives of the Partnership

The primary goal of this collaboration is to implement a comprehensive approach to risk management in clinical studies. The innovative registry solutions offered by VCT are designed to detect and prevent duplicate study enrollments and critical protocol violations during the screening process. Such measures are essential to safeguard participant safety, maintain data integrity, and navigate operational and regulatory challenges that could derail a study.

Benefits of the Alliance

1. Enhanced Participant Safety: By reducing the risk of overlapping study participations, the alliance aims to mitigate adverse events arising from drug interactions and other safety concerns.

2. Improved Data Quality: This partnership will support the dissemination of cleaner and more reliable study data, which will lead to more meaningful analyses, informed decision-making, and successful submissions to regulatory bodies.

3. Strengthened Study Integrity: Upholding adherence to protocols becomes easier, which safeguards the validity of clinical trials.

4. Reduced Risk Exposure: Chubb will assist sponsors, contract research organizations (CROs), and study sites in minimizing avoidable operational, financial, regulatory, and liability dangers.

5. Increased Trial Success Rates: A well-protected study environment enhances the likelihood of achieving research objectives.

6. Greater Public Benefit: This collaboration ultimately supports the development of safer, more effective drugs and therapies for patients and vulnerable populations.

Insights from the Leaders

Chubb stands out as the leading insurer for clinical trials, renowned for its customized insurance solutions tailored to life sciences organizations. Their resources and expertise equip pharmaceutical and biotechnology companies—ranging from emerging innovators to global giants—with the necessary defenses against adverse events and protocol deviations tied to double or undisclosed study participations.

Dr. Mitchell Efros, co-founder and CEO of Verified Clinical Trials, emphasized, "The safety of study participants and data integrity are foundational for any successful clinical study. This partnership with Chubb opens up an important opportunity to provide more protection, oversight, and added value to the clinical research ecosystem. Ultimately, the wider public benefits as safer and more effective drugs and therapies become available with greater confidence for patient application."

Lee Farrow, a business unit leader at Chubb, echoed the sentiment, asserting their commitment to innovative, practical risk management strategies in clinical research. "VCT addresses a longstanding issue in clinical trials—the inability to reliably verify a participant's research history to confirm their eligibility. Our alliance with VCT reflects a shared focus on improving participant safety, study integrity, and the overall performance of clinical research."

Kerri Weingard, co-founder and global operations leader at VCT, noted, "Our mission has always centered on strengthening the integrity of clinical research while prioritizing participant safety. This alliance marks a significant advancement in the industry’s approach to risk management, shifting from reactive measures to proactive safeguards. Combining our real-time participant verification with Chubb's global risk management expertise, we aim to create a safer, more transparent, and reliable ecosystem for clinical trials that ultimately benefits sponsors, sites, and, most importantly, patients."

A New Era for Clinical Trials

This strategic alliance highlights a crucial step toward promoting proactive risk management in clinical trials. It reiterates the invaluable collaboration between insurers and leading clinical trial technology providers, working together to achieve better outcomes in clinical research worldwide.

Verified Clinical Trials (VCT) specializes in participant registry solutions aimed at identifying and preventing duplicate enrollment and other protocol violations. Their robust global database is trusted by study sites, sponsors, and CROs, contributing to improved safety, compliance, and data quality in clinical research.

Chubb, with operations in 54 countries, offers a wide range of insurance solutions, including commercial and personal insurance, and is publicly listed on the New York Stock Exchange. With approximately 45,000 employees globally, Chubb continues to establish its strength in the market, providing reliable products and exceptional service to clients around the world.